IBD in older adults is climbing worldwide, and projections through 2040 show no sign of slowing.
Haiyan Li, Qinkai Li, Wen Tang, et al.
This analysis models the burden of inflammatory bowel disease and its subtypes among older adults across 172 high- and middle-income countries from 2000 to 2023, with projections extending to 2040. It highlights an aging-driven rise in disease burden that is expected to continue, underscoring the need for health systems to plan for a growing population of elderly IBD patients.
- The question: How is inflammatory bowel disease burden changing among older adults, and where is it heading?
- The study: This analysis modeled the burden of IBD and its subtypes across 172 high- and middle-income countries, from 2000 to 2023.
- The finding: It found an aging-driven rise in disease burden, and projections extending to 2040 expect that rise to continue.
- The nuance: That means health systems must plan for a growing population of elderly patients living with inflammatory bowel disease.
Takeaway: an aging world means more older IBD patients, so plan services for them now.
Narrated (standard AI voice, not a cloned voice) with burned-in captions matching the narration word-for-word — safe to watch muted. Built from this article’s SGA Briefing only.
This links to the publisher’s open-access copy of record. A self-hosted PDF will appear here once one is on file.